D. N. Wilson and K. H. Nierhaus, The ribosome through the looking glass, Angew. Chem. Int. Ed. Engl, vol.42, pp.3464-3486, 2003.

J. Nilsson and P. Nissen, Elongation factors on the ribosome, EF-Tu Frateuria W315 ( ) and EF

, The hydrolysis of [g-32 P]GTP was determined as described in the methods. The concentration of preformed EF-Tu[g-32 P] GTP complex was determined by nitrocellulose binding assay from the radioactivity bound to EF-Tu products in the presence of a saturating amount of, the absence (A) or in the presence of 50 mM kirromycin (B) or 50 mM enacyloxin IIa (C)

, Biol, vol.15, pp.349-354, 2005.

D. Kavaliauskas, P. Nissen, and C. R. Knudsen, The busiest of all ribosomal assistants: elongation factor Tu, Biochemistry, vol.51, pp.2642-2651, 2012.

A. Bashan, I. Agmon, R. Zarivach, F. Schluenzen, J. Harms et al., Structural basis of the ribosomal machinery for peptide bond formation, translocation, and nascent chain progression, Mol. Cell, vol.11, pp.91-102, 2003.

A. Parmeggiani and P. Nissen, Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action, FEBS Lett, vol.580, pp.4576-4581, 2006.

T. Watanabe, K. Izaki, and H. Takahashi, New polyenic antibiotics active against gram-positive and-negative bacteria. I. Isolation and purification of antibiotics produced by Gluconobacter sp. W-315, J. Antibiot, pp.1141-1147, 1982.

T. Watanabe, N. Okubo, T. Suzuki, and K. Izaki, New polyenic antibiotics active against gram-positive and gram-negative bacteria. VI. Non-lactonic polyene antibiotic, enacyloxin IIa, inhibits binding of aminoacyl-tRNA to A site of ribosomes, J. Antibiot, pp.572-574, 1992.

T. Watanabe, T. Suzuki, and K. Izaki, New polyenic antibiotics active against grampositive and gram-negative bacteria. V. Mode of action of enacyloxin IIa, J. Antibiot, pp.1457-1459, 1991.

R. Cetin, I. M. Krab, P. H. Anborgh, R. H. Cool, T. Watanabe et al., Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome, EMBO J, vol.15, pp.2604-2611, 1996.

I. M. Krab, A. Parmeggiani, . Mechanisms, and . Ef-tu, Prog. Nucleic Acid. Res. Mol. Biol, vol.71, pp.513-551, 2002.

T. Hogg, J. R. Mesters, and R. Hilgenfeld, Inhibitory mechanisms of antibiotics targeting elongation factor Tu, Curr. Protein Pept. Sci, vol.3, pp.121-131, 2002.

H. Wolf, D. Assmann, and E. Fischer, Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA, Proc. Natl. Acad. Sci. U. S. A, vol.75, pp.5324-5328, 1978.

P. H. Anborgh and A. Parmeggiani, New antibiotic that acts specifically on the GTPbound form of elongation factor Tu, EMBO J, vol.10, pp.779-784, 1991.

P. H. Anborgh, S. Okamura, and A. Parmeggiani, Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics, Biochemistry, vol.43, pp.15550-15556, 2004.

A. Parmeggiani, I. M. Krab, S. Okamura, R. C. Nielsen, J. Nyborg et al., Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu, vol.45, pp.6846-6857, 2006.

A. M. Zuurmond, L. N. Olsthoorn-tieleman, J. Martien-de-graaf, A. Parmeggiani, and B. Kraal, Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome, J. Mol. Biol, vol.294, pp.627-637, 1999.

M. Salanoubat, S. Genin, F. Artiguenave, J. Gouzy, S. Mangenot et al., Genome sequence of the plant pathogen Ralstonia solanacearum, Nature, vol.415, pp.497-502, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00427300

I. M. Krab and A. Parmeggiani, Functional-structural analysis of threonine 25, a residue coordinating the nucleotide-bound magnesium in elongation factor Tu, J. Biol. Chem, vol.274, pp.11132-11138, 1999.

P. H. Anborgh and A. Parmeggiani, Probing the reactivity of the GTP-and GDPbound conformations of elongation factor Tu in complex with the antibiotic GE2270 A, J. Biol. Chem, vol.268, pp.24622-24628, 1993.

R. J. Smith, D. H. Williams, J. C. Barna, I. R. Mcdermott, K. D. Haegele et al., Structure revision of the antibiotic Pulvomycin, J. Am. Chem. Soc, vol.107, pp.2849-2857, 1985.

G. Chinali and A. Parmeggiani, Properties of the elongation factors from Escherichia coli. Exchange of elongation factor G during elongation of polypeptide chain, Eur. J. Biochem, vol.32, pp.463-472, 1973.

I. M. Krab, R. Te-biesebeke, A. Bernardi, and A. Parmeggiani, Elongation factor Ts can act as a steric chaperone by increasing the solubility of nucleotide bindingimpaired elongation factor-Tu, Biochemistry, vol.40, pp.8531-8535, 2001.

J. B. Crechet, D. Canceill, V. Bocchini, and A. Parmeggiani, Characterization of the elongation factors from calf brain. 1. Purification, molecular and immunological properties, Eur. J. Biochem, vol.161, pp.635-645, 1986.

O. Fasano, W. Bruns, J. B. Crechet, G. Sander, and A. Parmeggiani, Modification of elongation-factor-Tu. guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts, Eur. J. Biochem, vol.89, pp.557-565, 1978.

R. Oyama, T. Watanabe, H. Hanzawa, T. Sano, T. Sugiyama et al., An extracellular Quinoprotein oxidase that catalyses conversion of Enacyloxin IVa to Enacyloxin IIa, Biosci. Biotechnol. Biochem, vol.58, 1994.

H. Wolf, G. Chinali, and A. Parmeggiani, Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes, Eur. J. Biochem, vol.75, pp.67-75, 1977.

D. Picone and A. Parmeggiani, Transfer ribonucleic acid deprived of the C-C-A 3 0extremity can interact with elongation factor Tu, Biochemistry, vol.22, pp.4400-4405, 1983.

O. Fasano, J. B. Crechet, and A. Parmeggiani, Preparation of nucleotide-free elongation factor Tu and its stabilization by the antibiotic kirromycin, Anal. Biochem, vol.124, pp.53-58, 1982.

T. Watanabe, T. Sugiyama, and K. Izaki, New polyenic antibiotics active against gram-positive and gram-negative bacteria. IX. Reclassification of a strain W315 producing enacyloxins, J. Antibiot. (Tokyo), pp.496-498, 1994.

A. Parmeggiani, I. M. Krab, T. Watanabe, R. C. Nielsen, C. Dahlberg et al., Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics, J. Biol. Chem, vol.281, pp.2893-2900, 2006.

H. Berchtold, L. Reshetnikova, C. O. Reiser, N. K. Schirmer, M. Sprinzl et al., Crystal structure of active elongation factor Tu reveals major domain rearrangements, Nature, vol.365, pp.126-132, 1993.

M. Kjeldgaard, P. Nissen, S. Thirup, and J. Nyborg, The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation, Structure, vol.1, pp.35-50, 1993.

K. Abel, M. D. Yoder, R. Hilgenfeld, and F. Jurnak, An alpha to beta conformational switch in EF-Tu, vol.4, pp.1153-1159, 1996.

G. Polekhina, S. Thirup, M. Kjeldgaard, P. Nissen, C. Lippmann et al., Helix unwinding in the effector region of elongation factor EF-Tu-GDP, Structure, vol.4, pp.1141-1151, 1996.

L. Vogeley, G. J. Palm, J. R. Mesters, and R. Hilgenfeld, Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox, J. Biol. Chem, vol.276, pp.17149-17155, 2001.

T. Daviter, H. J. Wieden, and M. V. Rodnina, Essential role of histidine 84 in elongation factor Tu for the chemical step of GTP hydrolysis on the ribosome, J. Mol. Biol, vol.332, pp.689-699, 2003.

R. H. Cool and A. Parmeggiani, Substitution of histidine-84 and the GTPase mechanism of elongation factor Tu, Biochemistry, vol.30, pp.362-366, 1991.

G. Scarano, I. M. Krab, V. Bocchini, and A. Parmeggiani, Relevance of histidine-84 in the elongation factor Tu GTPase activity and in poly(Phe) synthesis: its substitution by glutamine and alanine, FEBS Lett, vol.365, pp.214-218, 1995.